AGWCA
MD icon

Annis Gardner Whiting Capital Advisors’s Pediatrix Medical MD Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$43 – 1367
2025
Q4 		$43 Buy
+2
New +$41 ﹤0.01% 1192

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's MD Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 2 shares — an estimated $43 sold.

Annis Gardner Whiting Capital Advisors first reported a position in MD in Q4 2025 and held it in 1 quarter. The position peaked at $43 in Q4 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 2 Pediatrix Medical shares in Q1 2026, an estimated $43.
  • Annis Gardner Whiting Capital Advisors first reported a position in Pediatrix Medical in Q4 2025 and held it in 1 quarter.
  • Annis Gardner Whiting Capital Advisors's Pediatrix Medical position peaked at $43 in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.